Valuation: Coral Laboratories Limited

Market Cap 132.38Cr 1.39Cr 1.21Cr 1.12Cr 1.04Cr 1.96Cr 2Cr 13Cr 5.25Cr 65Cr 5.21Cr 5.09Cr 225.18Cr P/E 2024
8.4x
P/E 2025 10.4x
Enterprise Value 104.99Cr 1.1Cr 96.22L 88.73L 82.1L 1.56Cr 1.58Cr 11Cr 4.17Cr 52Cr 4.13Cr 4.04Cr 178.59Cr EV / Sales 2024
1.25x
EV / Sales 2025 1.94x
Free-Float
19.98%
Yield 2024
0.54%
Yield 2025 0.21%
1 day+2.17%
1 week-2.51%
Current month-4.71%
1 month+17.73%
3 months+46.11%
6 months+32.56%
Current year+34.30%
1 week 570.75
Extreme 570.75
620
1 month 475
Extreme 475
659
Current year 360
Extreme 360
659
1 year 360
Extreme 360
659
3 years 230
Extreme 230
999
5 years 217
Extreme 217
999
10 years 81.2
Extreme 81.2
1,190
Manager TitleAgeSince
Director of Finance/CFO 49 26/05/2017
Director TitleAgeSince
Director/Board Member 45 26/05/2017
Director/Board Member 49 26/05/2017
Director/Board Member 40 28/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
+2.17%-2.51%+0.18%+142.35% 2.15Cr
+0.09%+0.25%+54.65%+169.19% 1,08400Cr
-1.63%-1.50%+65.79%+62.70% 63TCr
-1.12%-4.27%+31.10%+84.44% 45TCr
+0.18%-1.76%+29.04%+26.51% 33TCr
-6.22%-8.14%+28.87%+32.09% 30TCr
-1.27%-2.91%+27.42%+46.39% 28TCr
-0.93%-3.57%-27.74%-40.38% 22TCr
-1.19%-2.81%+22.63%+66.30% 20TCr
-0.72%+2.72%+19.07%+81.19% 17TCr
Average -0.93%-1.67%+25.10%+67.08% 36.6TCr
Weighted average by Cap. -0.90%-1.18%+38.91%+84.80%

Financials

2024 2025
Net sales 84Cr 87.65L 76.67L 70.71L 65.42L 1.24Cr 1.26Cr 8.47Cr 3.32Cr 41Cr 3.29Cr 3.22Cr 142.31Cr 115.01Cr 1.2Cr 1.05Cr 97.2L 89.93L 1.71Cr 1.74Cr 12Cr 4.56Cr 56Cr 4.52Cr 4.43Cr 195.62Cr
Net income 16Cr 16.54L 14.47L 13.34L 12.35L 23.43L 23.83L 1.6Cr 62.64L 7.75Cr 62.1L 60.75L 27Cr 24Cr 25.31L 22.14L 20.42L 18.89L 35.85L 36.45L 2.44Cr 95.84L 12Cr 95L 92.95L 41Cr
Net Debt -28Cr -29.11L -25.47L -23.48L -21.73L -41.24L -41.93L -2.81Cr -1.1Cr -14Cr -1.09Cr -1.07Cr -47Cr -27Cr -28.69L -25.1L -23.15L -21.42L -40.65L -41.33L -2.77Cr -1.09Cr -13Cr -1.08Cr -1.05Cr -47Cr
Logo Coral Laboratories Limited
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
Employees
197
Date Price Change Volume
09/26/09 ₹588.90 +2.17% 370
08/26/08 ₹576.40 -4.05% 1,105
07/26/07 ₹600.75 -2.24% 501
06/26/06 ₹614.50 +1.48% 322
03/26/03 ₹605.55 +0.25% 945
  1. Stock Market
  2. Stocks
  3. CORALAB6 Stock